Lallemand Health Solutions and ComboCap® Inc., announce exclusive partnership.


The companies to launch an innovative new global probiotics product category using dual chamber capsule technology.


Montreal, Canada Lallemand Health Solutions, a pioneer in probiotic solutions and ComboCap® Inc., the creators of the new global ComboCap® product category are excited to announce their long-term exclusive partnership and license agreement for the co-development of unique side-by-side dual-chamber wet-and-dry probiotic ComboCap® products.

This new partnership will allow for the conception of first-to-market solutions for unlimited oral wet-and-dry ComboCap_Lallemand_Health Solutions.probiotic combinations previously unavailable because of ingredient incompatibility.  This technology allows for greater product stability and the creation of entirely new possibilities for dual-dose combinations. It works by inserting a membrane into a regular capsule so that the capsule can carry two components together-but-separate. This new separated probiotics products category is an ideal choice for the creation of new exciting and effective product extensions and brand ranges.  We also believe this new solution will allow for a broader nutritional offering to consumers which means a more significant potential for better long term results, improved compliance, and the creation of unique products.

The key benefits of probiotic ComboCap® products containing clinically documented Harmonium, Lafti® or Rosell® probiotic strains from Lallemand Health Solutions are:

  • an unlimited efficacy of potential dual-dose combinations, including probiotic strains + liquids or pastes such as Omega oils, CBD oils, botanical extracts
  • a large chamber size and sealed in liquids
  • a moveable membrane to control and vary dosing

This new product category offering will allow companies to bring added convenience and value to their product lines by creating a range of products that are unique, have high visual appeal, and are simple for consumers to use.

“We are incredibly proud to be ComboCap®’s new strategic partner. This is a new step for us as an innovative health-centric organization to research further, develop and create new custom ready-to-market probiotic solutions that positively impact human health,” said Jérôme Panes, President and General Manager of Lallemand Health Solutions.

“We’re very excited to be partnering with the excellent team at Lallemand to grow probiotic ComboCap® products globally in this newly formed combinations health products category.  We look forward to working together to expand new brand and consumer frontiers for the industry in general and our customer,” said Tobie Louw, CEO of ComboCap.

For more information on this exciting new product offering, please contact Isabelle Champié, Lallemand Sales and Marketing Director at


About Lallemand

Lallemand Inc. is a privately owned Canadian company specializing in the development, production, and marketing of yeast, bacteria, and other ingredients linked to these microorganisms or their industries.

Lallemand Health Solutions

Backed by 85 years of science and expertise in probiotic research and development, Lallemand Health Solutions offers a full line of over 500 ready-to-market probiotic formulas and can help their partners design their own custom formulations using Harmonium, Lafti® or Rosell® probiotic strains and our proprietary protective technologies. Lallemand Health Solutions controls the manufacturing process of its products from lab to the shelf, to ensure customers receive the highest quality probiotic formulation. As a vertically integrated manufacturer, we guarantee our partners receive the full support they need to develop, register, and market their products, making Lallemand Health Solutions a complete probiotic solutions provider.

Lallemand Health Solutions covers more than 60 countries across five continents and is ready to service your probiotic needs. For more information, please visit, or contact

About ComboCap, Inc.

ComboCap, Inc. is an innovative product development company that has introduced the world’s first side-by-side, dual-chamber, wet-and-dry combination capsule product with a movable membrane. ComboCap® products represent an entirely new category of combination therapies for the pharmaceutical & nutraceutical industries. Our patented technology targets the burgeoning global combination therapy products market where no universally attractive “wet & dry,” split-dose solution exists. ComboCap has developed specialized manufacturing equipment and services to offer customized products as well as turn-key customized finished product solutions to clients worldwide.


Isabelle Champié
Sales and Marketing Director